Iva Košuta
Iva Košuta
University Hospital Merkur
Potvrđena adresa e-pošte na kb-merkur.hr
NaslovCitiranoGodina
Drug-induced liver injury associated with Noni (Morinda citrifolia) juice and phenobarbital
A Mrzljak, I Kosuta, A Skrtic, TF Kanizaj, R Vrhovac
Case reports in gastroenterology 7 (1), 19-24, 2013
272013
Metachronous gastrointestinal stromal tumor and acute leukemia after liver transplantation for cholangiocellular carcinoma: is there a link
A Mrzljak, I Košuta, A Škrtić, I Kardum-Skelin, R Vrhovac
Case reports in oncology 6 (1), 163-168, 2013
162013
Relationship between tumor vascularity and vascular endothelial growth factor as prognostic factors for patients with neuroblastoma
G Jakovljević, S Čulić, J Stepan, I Košuta, S Seiwerth
Collegium antropologicum 35 (4), 1071-1079, 2011
52011
INFEKCIJE U BOLESNIKA S CIROZOM I TRANSPLANTACIJOM JETRE
T FILIPEC KANIŽAJ, IVA KOŠUTA, G CAVRIĆ
Acta Medica Croatica 69 (3), 135-143, 2016
12016
Bloodstream infections after liver and hematopoietic stem cell transplantation
Z Perić, A TAMbIć-ANDrAševIć, ANA MrZlJAK, I Košuta, V Kovačević, ...
Acta Medica Croatica 66 (5), 365-372, 2013
12013
Hemosuccus Pancreaticus Associated with Splenic Artery Aneurysms and Hepatic Artery Thrombosis Late After Liver Transplantation
A Mrzljak, N Sobočan, K Novačić, D Škegro, I Košuta, M Katičić
JOP. Journal of the Pancreas 13 (1), 115-117, 2012
12012
Platelet-derived growth factor alpha might mediate hepatic fibrosis by enhancing insulin resistance in patients with hepatitis C
A Mrzljak, D Dusek, K Blaslov, SZ Lepej, I Grgić, L Gorenec, I Košuta, ...
Journal of hepatology 70, E501-E501, 2019
2019
Leatin-independent risk factor for insulin resistance in liver cirrhosis
I Košuta, A Mrzljak, B Kolarić, MV Lovrenčić
10. Internistički kongres, 2018
2018
Hepatotoxicity of ayurvedic herbal medicine
L Franušić, I Košuta, A Vince, A Škrtić, A Mrzljak
10. Internistički kongres, 2018
2018
Serum asymmetric dimethylarginine in cirrhosis
E Kruezi, M Dragičević, MV Lovrenčić, I Košuta, A Mrzljak
10. Internistički kongres, 2018
2018
Lipid profiles in alcohol-induced cirrhosis and their association with prognostic scores
M Mrčelić, R Astudillo, I Košuta, S Perkov, Z Flegar-Meštrić, A Mrzljak
10. Internistički kongres, 2018
2018
FRI-021-Short-term metabolic alterations following liver transplantation
I Košuta, MV Lovrenčić, A Mrzljak
Journal of Hepatology 66 (1), S376, 2017
2017
Outcome analysis of liver grafts from anti-hepatitis B core positive donors
A Mrzljak, PD Kujundžić, M Miletić, A Ostojić, L Čakalo, I Košuta, ...
1. kongres Hrvatskog društva za transplantacijsku medicinu, 2017
2017
LIVER TRANSPLANTATION AMELIORATES ADIPONECTIN DISTURBANCES IN ALCOHOLIC LIVER CIRRHOSIS
I Kosuta, MV Lovrencic, M Dragicevic, A Mrzljak
TRANSPLANT INTERNATIONAL 30, 236-236, 2017
2017
HEPATITIS B AND C SEROLOGICAL PROFILES OF LIVER/KIDNEY DONORS AND RECIPIENTS: 10-YEAR CROATIAN SINGLE CENTRE ANALYSIS
A Zljak, PD Kujundzic, B Gardijan, M Miletic, A Ostojic, I Kosuta, D Mikulic, ...
TRANSPLANT INTERNATIONAL 30, 435-435, 2017
2017
RED BLOOD CELL ANTIBODIES IN PATIENTS UNDERGOING LIVER TRANSPLANTATION: A CROATIAN SINGLE CENTRE ANALYSIS
M Lukic, MK Radovcic, I Kosuta, B Kocman, A Mrzljak
TRANSPLANT INTERNATIONAL 30, 390-390, 2017
2017
Transarterial Chemoembolization Prior to Liver Transplantation in Patients with Hepatocellular Carcinoma-a single-center experience.
A Ostojić, PD Kujundžić, I Košuta, S Nikola, S Gašparov, M Slavica, ...
EASL HCC Summit, 2017
2017
Hepatitis B core antibody-positive donors in liver transplantation.
A Mrzljak, PD Kujundžić, M Miletić, A Ostojić, I Košuta, N Kunac, ...
11th Croatian Congress of Clinical Microbiology and 8th Croatian Congress of …, 2016
2016
Asymmetric dimethylarginine levels and the severity of the liver disease
M Dragičević, I Košuta, E Kruezi, A Višnjić, A Mrzljak, MV Lovrenčić
Falk Symposium 205: New Treatment Targets in Gut and Liver Disease, 2016
2016
Advanced liver disease and insulin resistance-is there a connection?
I Košuta, S Šundalić, M Dragičević, A Višnjić, MV Lovrenčić, A Mrzljak
Falk symposium 204: Clinical hepatology practice in 2016: From science to …, 2016
2016
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20